Section 4: Clinical Pharmacy Services

4CPS-213

ASSESSING AND COMPARING A PRE-DISCHARGE MEDICATION RECONCILIATION MODEL TO A POSTDISCHARGE MODEL

4CPS-205

INTRAVENOUS MEDICINE COMPATIBILITY: AN EVALUATION OF HOSPITAL PRACTICES

4CPS-198

ADVERSE DRUG REACTIONS REPORTING: AWARENESS, KNOWLEDGE AND REASONS FOR UNDER-REPORTING AMONG HOPITAL PHARMACISTS IN MACEDONIA

4CPS-195

MASTERING THE COLONOSCOPY BOWEL PREPARATION OF PATIENTS: A MULTIDISCIPLINARY HEALTHCARE APPROACH

4CPS-181

STUDY OF THE REASONS FOR THE THERAPEUTIC DISCONTINUATION OF IMMUNE-BASED THERAPIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS

4CPS-178

MANAGEMENT OF DELIRIUM IN AN ACUTE CARE HOSPITAL

4CPS-176

PSYCHIATRIC DISORDERS AND CARDIOPULMONARY ARREST PROBABLY RELATED TO PRESCRIBING CASCADE

4CPS-175

SAFE USE OF LEVETIRACETAM AT DOSES HIGHER THAN THE MAXIMUM RECOMMENDED

4CPS-173

CANCER PAIN ASSESSMENT AND ASSOCIATED ANALGESICS PRESCRIPTIONS

4CPS-163

ECULIZUMAB THERAPY FOR ADULT RENAL TRANSPLANT IN AHUS WITH MUTATION IN THE CFH GENE: A CASE REPORT

4CPS-162

INFLIXIMAB SERUM CONCENTRATIONS, ANTIBODY FORMATION AND CLINICAL RESPONSE IN PSORIATIC PATIENTS

4CPS-160

USE OF APREMILAST IN PLAQUE PSORIASIS AS AN ALTERNATIVE TO BIOLOGIC TREATMENTS

4CPS-159

QUALITY OF LIFE ASSESSMENT AND EFFICACY OF SECUKINUMAB IN PLAQUE PSORIASIS DISEASE

4CPS-158

OPTIMISATION OF BIOLOGICAL THERAPIES AND ECONOMIC IMPACT ANALYSIS

4CPS-157

VEDOLIZUMAB: EARLY EXPERIENCE AND MEDIUMTERM OUTCOMES IN INFLAMMATORY BOWEL DISEASE

Pages